496
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE)

, &
Pages 124-130 | Received 27 Apr 2013, Accepted 20 Sep 2013, Published online: 04 Nov 2013

References

  • Fisher RA. The design of experiments. London: Oliver and Boyd; 1935:35–8
  • Nekkanti V, Muniyappan T, Karatgi P, et al. Spray-drying process optimization for manufacture of drug-cyclodextrin complex powder using design of experiments. Drug Dev Ind Pharm 2009;35:1219–29
  • Guidance for industry, quality system approach to pharmaceutical CGMP regulations. 2006. Available from: http://www.fda.gov/downloads/Drugs/.../Guidances/UCM070337.pdf [last accessed 27 Aug 2013]
  • Billon A, Bataille B, Cassanas G, Jacob M. Development of spray-dried acetaminophen microparticles using experimental designs. Int J Pharm 2000;203:159–68
  • Vaithiyalingam S, Khan MA. Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion. Int J Pharm 2002;234:179–93
  • Tewa-Tagne P, Briançon S, Fessi H. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics. Int J Pharm 2006;325:63–74
  • Dévay A, Mayer K, Pál S, Antal I. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation. J Biochem Biophys Methods 2006;69:197–205
  • Nekkanti V, Karatgi P, Joshi M, Pillai R. Developing nanoparticle formulations or poorly soluble drugs. Phar Tech Eur 2008;11:24–8
  • Verma S, Lan Y, Gokhale R, Burgess DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm 2009;377:185–98
  • Zidan AS, Sammour OA, Hammad MA, et al. Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box–Behnken design and desirability function. Int J Pharm 2007;332:55–63
  • Singare DS, Marella S, Gowthamrajan K, et al. Optimization of formulation and process variable of nanosuspension: an industrial perspective. Int J Pharm 2010;402:213–20
  • Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003;18:113–20
  • Box GE, Hunter WG, Hunter JS. Statistics for experimenters: an introduction to design, data analysis, and model building. New York: Wiley; 1978:313--19
  • Liberman H, Rieger M, Banker G. Pharmaceutical dosage forms: disperse systems. New York: Mercel Dekker; 1989:438–64
  • Derringer GC. A balancing act-optimizing a products properties. Qual Prog 1994;27:51–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.